|
Marketing
The Seven Deadly Sins of Product Launches
As more new products vie for payer and prescriber attention, the stakes around launch success are higher than ever. Stan Bernard outlines the key traps to avoid in getting things right – when it really counts ...Read more
learn more about how to leverage Data and Analytics to enhance Copay Program Performance with this White Paper and Case Study:
 Read more
Leadership
Adapt or Die: Nine Lessons from the Battlefield
For Rick Lynch, the General who led the Iraqi 'surge' campaign, a key consideration in sustaining pharma as a thriving business of this is effective, adaptive leadership. Here he cites nine lessons from his long Army history that pharma leaders can apply in today's come-from-behind struggle for market share
...Read more
Leadership
Pharm Exec's 2015 Emerging Pharma Leaders — Nominate Now!
Pharm Exec is looking for the fresh faces of pharma leadership, and we'd like your input! Tell us who you think should be included as one of Pharmaceutical Executive's 2015 Emerging Pharma Leaders. Read more for details of how to nominate a colleague — or yourself. The deadline for this year's entries is April 15 ...Read more
Regulatory
After Hamburg: What Next for FDA?
Following Commissioner Margaret Hamburg's announcement that she is to leave FDA in March, Jill Wechsler looks at her achievements and considers the new candidates for the job
...Read more
Forecast
What's Ahead? Pharm Exec's 2015 Industry Forecast
Following a year where a phenomenal cure was met by pricing outrage, the march of new products and promising immunotherapy cancer combos will continue in 2015. As pharma and tech jell, how will the industry live up to its value supposition while pricing and profiting in the developed and developing worlds? ...Read more
|
